In 2012, Washington and Colorado became the first states to legalize recreational marijuana use. By 2020, it’s expected that marijuana will grow to a $21 billion a year industry.
ETF investors who have been clamoring for a good way to get in on the cannabis trend have largely been unserved. There’s the recently launched Horizons Marijuana Life Sciences ETF (HMMJ) but that only trades on the Toronto Stock Exchange. That’s about to change as the ETFMG Alternative Agroscience ETF is scheduled to begin trading later in December.
The environmental, social and governance sub-sector of the fund space is seen as a growth frontier for exchange-traded funds and ETF issuers are responding to that theme. On Tuesday, California-based Inspire Investing bolstered its lineup of Christian values ETFs with the debut of the Inspire 100 ETF BIBL.
“All of our funds are built using our Inspire Impact score methodology, which identifies the most inspiring biblically aligned companies in the world,” said Inspire CEO Robert Netzly.
Since reflation trades topped out between December and February, Cyclical sectors and Financials have underperformed. During this period, growth stocks and especially Big Technology have widely outperformed, followed by Consumer Discretionary, also a growth sector, as well as Defensive sectors (Staples, Healthcare, Utilities). We believe that these rotations should reverse during the Summer, as Growth and Defensives handover to Financials and Cyclical and give life to a second leg up for reflation assets towards early 2018.
On Wednesday, April 5th the Horizons Medical Marijuana Life Sciences ETF began trading on the TSX. HMMJ is the first ever ETF offing investors direct exposure to a basket of cannabis related companies in Canada and the United States. According to its website, its stake didn’t exceed 10 percent in any individual company.
The Horizons Medical Marijuana Life Sciences ETF seeks to track the Solactive North American Medical Marijuana Index and it offers a way to invest without taking on individual company risk. However, the ETF only holds a total of 14 stocks, and while billed as a global fund, 10 holdings are Canadian-based. The medical marijuana industry is more developed in Canada than in other nations, and cannabis could soon become legal for all Canadian adults.
Fed policy makers signalled an interest-rate hike in April is unlikely, minutes of the March policy meeting showed, confirming market’s growing anticipation that the US central bank will act cautiously […]
Both equity markets and the euro are lower on Tuesday after what appears to be a coordinated terrorist attack in Brussels. Belgium is now on its highest terror alert after […]
Year to date a record level of net new assets have been gathered by commodity ETFs/ETPs with US$12.28 Bn, leveraged ETFs/ETPs with US$5.61 and Inverse ETFs/ETPs with US$1.41 Bn.
2016 has, so far, been a volatile and tumultuous year for financial markets. Only three weeks in, we have already seen a multitude of news events causing risk aversion to spike. These include, to name just a few, the tumbling price of oil, a myriad of different policy moves from the Chinese authorities, conflicting indicators of Chinese economic growth and subsequent fears of slower global growth, yet more idiosyncratic corporate events and geopolitical events.
For qualified investors / professional clients only
In order to proceed, you must confirm that you are a qualified investor based in Switzerland
The information contained in this section have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document.
Before investing in a product please read the latest prospectus carefully and thoroughly and note that funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided without any guarantee or warranty and are for the recipient's personal use and information purposes only
